# CHIPOR (NCT01376752)

> Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment

No report yet. It can be ordered.

- Indication: recurrent ovarian cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01376752
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: UNICANCER
- Conditions: Ovarian Epithelial Cancer Recurrent
- Interventions: Maximal cytoreductive surgery; HIPEC
- Enrollment: 415
- Primary outcome: overall survival

## Indexed commentary on CHIPOR so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 12 posts on X
- 4 YouTube videos
- 3 podcast episodes

## Order

Standard, $1,250 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=chipor-nct01376752

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01376752", "email": "<work email>"}; the inbox owner confirms by the emailed link.